• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门克斯病的早期临床症状与治疗

Early clinical signs and treatment of Menkes disease.

作者信息

Fujisawa Chie, Kodama Hiroko, Sato Yasuhiro, Mimaki Masakazu, Yagi Mariko, Awano Hiroyuki, Matsuo Muneaki, Shintaku Haruo, Yoshida Sayaka, Takayanagi Masaki, Kubota Mitsuru, Takahashi Akihito, Akasaka Yoshikiyo

机构信息

Department of Pediatrics, School of Medicine, Teikyo University, Itabashi-ku, Tokyo 173-8606, Japan.

Department of Research Unit, Faculty of Medicine, Toho University, Ota-ku, Tokyo 143-8540, Japan.

出版信息

Mol Genet Metab Rep. 2022 Feb 17;31:100849. doi: 10.1016/j.ymgmr.2022.100849. eCollection 2022 Jun.

DOI:10.1016/j.ymgmr.2022.100849
PMID:35242581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8861833/
Abstract

Menkes disease (MD) is an X-linked recessive disorder caused by mutations in . Patients with MD exhibit severe neurological and connective tissue disorders due to copper deficiency and typically die before 3 years of age. Early treatment with copper injections during the neonatal period, before the occurrence of neurological symptoms, can alleviate neurological disturbances to some degree. We investigated whether early symptoms can help in the early diagnosis of MD. Abnormal hair growth, prolonged jaundice, and feeding difficulties were observed during the neonatal period in 20 of 69, 16 of 67, and 3 of 18 patients, respectively. Only three patients visited a physician during the neonatal period; MD diagnosis was not made at that point. The mean age at diagnosis was 8.7 months. Seven patients, who were diagnosed in the prenatal stage or soon after birth, as they had a family history of MD, received early treatment. No diagnosis was made based on early symptoms, highlighting the difficulty in diagnosing MD based on symptoms observed during the neonatal period. Patients who received early treatment lived longer than their elderly relatives with MD. Three patients could walk and did not have seizures. Therefore, effective newborn screening for MD should be prioritized.

摘要

门克斯病(MD)是一种由[基因名称]突变引起的X连锁隐性疾病。MD患者由于铜缺乏而表现出严重的神经和结缔组织紊乱,通常在3岁前死亡。在新生儿期出现神经症状之前进行铜注射早期治疗,可在一定程度上缓解神经功能障碍。我们研究了早期症状是否有助于MD的早期诊断。在69例患者中的20例、67例患者中的16例和18例患者中的3例新生儿期分别观察到毛发异常生长、黄疸持续时间延长和喂养困难。只有3例患者在新生儿期就诊;当时未作出MD诊断。诊断时的平均年龄为8.7个月。7例因有MD家族史而在产前阶段或出生后不久被诊断出的患者接受了早期治疗。未根据早期症状作出诊断,这突出了根据新生儿期观察到的症状诊断MD的困难。接受早期治疗的患者比患有MD的年长亲属寿命更长。3例患者能够行走且无癫痫发作。因此,应优先开展有效的MD新生儿筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/886f2dee4e8e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/826a0f460627/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/55110ed51fe0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/77fda5a909c9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/886f2dee4e8e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/826a0f460627/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/55110ed51fe0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/77fda5a909c9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a62/8861833/886f2dee4e8e/gr4.jpg

相似文献

1
Early clinical signs and treatment of Menkes disease.门克斯病的早期临床症状与治疗
Mol Genet Metab Rep. 2022 Feb 17;31:100849. doi: 10.1016/j.ymgmr.2022.100849. eCollection 2022 Jun.
2
Phenotypic and mutational spectrum of 17 Chinese patients with Menkes Disease.17例中国门克斯病患者的表型和突变谱
Neurol Sci. 2025 Jan;46(1):437-444. doi: 10.1007/s10072-024-07676-5. Epub 2024 Jul 6.
3
An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.导致 Menkes 病和枕骨角综合征的 ATP7A 突变的概述和更新。
Hum Mutat. 2013 Mar;34(3):417-29. doi: 10.1002/humu.22266.
4
Modeling of Menkes disease via human induced pluripotent stem cells.利用人诱导多能干细胞对 Menkes 病进行建模。
Biochem Biophys Res Commun. 2014 Feb 14;444(3):311-8. doi: 10.1016/j.bbrc.2014.01.038. Epub 2014 Jan 24.
5
Identification of novel ATP7A mutations and prenatal diagnosis in Chinese patients with Menkes disease.中国门克斯病患者中新型ATP7A突变的鉴定及产前诊断
Metab Brain Dis. 2017 Aug;32(4):1123-1131. doi: 10.1007/s11011-017-9985-4. Epub 2017 Apr 10.
6
A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.一位 37 岁的 Menkes 病患者——残余 ATP7A 活性和早期铜剂治疗作为关键因素。
Clin Genet. 2017 Nov;92(5):548-553. doi: 10.1111/cge.13083.
7
Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.门克斯病患者铜-组氨酸治疗的新突变及临床结果
Metab Brain Dis. 2015 Feb;30(1):75-81. doi: 10.1007/s11011-014-9569-5. Epub 2014 Jun 13.
8
A novel ATP7A gross deletion mutation in a Korean patient with Menkes disease.一名患有门克斯病的韩国患者中发现一种新的ATP7A大片段缺失突变。
Ann Clin Lab Sci. 2009 Spring;39(2):188-91.
9
A severe case of Menkes disease with repeated bone fracture during the neonatal period, followed by multiple arterial occlusion.1例严重的门克斯病,新生儿期反复发生骨折,随后出现多处动脉闭塞。
Brain Dev. 2019 Nov;41(10):878-882. doi: 10.1016/j.braindev.2019.06.005. Epub 2019 Jul 3.
10
Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A.对383名患门克斯病的非亲属患者进行筛查,并在ATP7A基因中发现57个大片段缺失。
Hum Mutat. 2003 Dec;22(6):457-64. doi: 10.1002/humu.10287.

引用本文的文献

1
A primer on copper biology in the brain.大脑中铜生物学入门
Neurobiol Dis. 2025 Aug;212:106974. doi: 10.1016/j.nbd.2025.106974. Epub 2025 May 23.
2
Two Cases of Menkes Disease With Similar Intracranial Arterial Tortuosity on Brain Magnetic Resonance Imaging.两例脑磁共振成像显示颅内动脉迂曲相似的门克斯病病例
Cureus. 2024 Nov 22;16(11):e74280. doi: 10.7759/cureus.74280. eCollection 2024 Nov.
3
Solvatomorphic Diversity in Coordination Compounds of Copper(II) with l-Homoserine and 1,10-Phenanthroline: Syntheses, Crystal Structures and ESR Study.

本文引用的文献

1
Pharmacokinetics of CuGTSM, a Novel Drug Candidate, in a Mouse Model of Menkes Disease.新型药物候选物 CuGTSM 在 Menkes 病小鼠模型中的药代动力学研究。
Pharm Res. 2021 Aug;38(8):1335-1344. doi: 10.1007/s11095-021-03090-0. Epub 2021 Aug 17.
2
Targeted next generation sequencing for newborn screening of Menkes disease.用于门克斯病新生儿筛查的靶向新一代测序技术。
Mol Genet Metab Rep. 2020 Jul 21;24:100625. doi: 10.1016/j.ymgmr.2020.100625. eCollection 2020 Sep.
3
ATP7A mutations in 66 Japanese patients with Menkes disease and carrier detection: A gene analysis.
铜(II)与L-高丝氨酸和1,10-菲咯啉配位化合物的溶剂化异构多样性:合成、晶体结构及电子自旋共振研究
Molecules. 2024 Nov 27;29(23):5621. doi: 10.3390/molecules29235621.
4
Adaptive protein synthesis in genetic models of copper deficiency and childhood neurodegeneration.铜缺乏与儿童神经退行性变遗传模型中的适应性蛋白质合成
bioRxiv. 2024 Nov 18:2024.09.09.612106. doi: 10.1101/2024.09.09.612106.
5
Recent progress of methods for cuproptosis detection.铜死亡检测方法的最新进展。
Front Mol Biosci. 2024 Sep 4;11:1460987. doi: 10.3389/fmolb.2024.1460987. eCollection 2024.
6
Cuproptosis: Mechanisms, biological significance, and advances in disease treatment-A systematic review.铜死亡:机制、生物学意义及在疾病治疗方面的进展——系统综述。
CNS Neurosci Ther. 2024 Sep;30(9):e70039. doi: 10.1111/cns.70039.
7
Mammalian copper homeostasis: physiological roles and molecular mechanisms.哺乳动物的铜稳态:生理作用和分子机制。
Physiol Rev. 2025 Jan 1;105(1):441-491. doi: 10.1152/physrev.00011.2024. Epub 2024 Aug 22.
8
Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases.铜死亡(Cuproptosis)和铜:细胞死亡的新范式及其在非癌症疾病中的作用。
Apoptosis. 2024 Oct;29(9-10):1330-1360. doi: 10.1007/s10495-024-01993-y. Epub 2024 Jul 16.
9
Coordination chemistry of mitochondrial copper metalloenzymes: exploring implications for copper dyshomeostasis in cell death.线粒体铜金属酶的配位化学:探索铜代谢失衡与细胞死亡的关系。
BMB Rep. 2023 Nov;56(11):575-583. doi: 10.5483/BMBRep.2023-0172.
10
Menkes disease complicated by concurrent ACY1 deficiency: A case report.门克斯病合并ACY1缺乏症:一例报告。
Front Genet. 2023 Mar 2;14:1077625. doi: 10.3389/fgene.2023.1077625. eCollection 2023.
66例日本门克斯病患者的ATP7A突变及携带者检测:基因分析
Pediatr Int. 2019 Apr;61(4):345-350. doi: 10.1111/ped.13817. Epub 2019 Apr 16.
4
A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease.一项针对 Menkes 病的诊断和治疗的系统评价和循证指南。
Mol Genet Metab. 2019 Jan;126(1):6-13. doi: 10.1016/j.ymgme.2018.12.005. Epub 2018 Dec 11.
5
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time.Menkes 病和 Wilson 病中的螯合原理:在正确的时间选择正确的组合中的正确化合物。
J Inorg Biochem. 2019 Jan;190:98-112. doi: 10.1016/j.jinorgbio.2018.10.009. Epub 2018 Oct 23.
6
A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.一位 37 岁的 Menkes 病患者——残余 ATP7A 活性和早期铜剂治疗作为关键因素。
Clin Genet. 2017 Nov;92(5):548-553. doi: 10.1111/cge.13083.
7
Mottled Mice and Non-Mammalian Models of Menkes Disease.斑驳小鼠与门克斯病的非哺乳动物模型
Front Mol Neurosci. 2015 Dec 18;8:72. doi: 10.3389/fnmol.2015.00072. eCollection 2015.
8
Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients.门克斯病中的癫痫:28例患者的电临床长期研究
Epilepsy Res. 2014 Nov;108(9):1597-603. doi: 10.1016/j.eplepsyres.2014.08.006. Epub 2014 Aug 30.
9
PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.用64Cu进行PET成像分析,用于双硫仑治疗门克斯病小鼠模型中异常铜生物分布的研究。
J Nucl Med. 2014 May;55(5):845-51. doi: 10.2967/jnumed.113.131797. Epub 2014 Mar 13.
10
Standard values for the urine HVA/VMA ratio in neonates as a screen for Menkes disease.新生儿尿中高香草酸/香草扁桃酸比值作为筛查门克斯病的标准值。
Brain Dev. 2015 Jan;37(1):114-9. doi: 10.1016/j.braindev.2014.01.014. Epub 2014 Feb 17.